Menu Search
Equities

Eurazeo SE

RFp:EBT

Eurazeo SE

Actions
  • Price (EUR)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Eurazeo SE is a France-based investment company. The Company owns a diversified portfolio of over 18 billion euro in assets under management in all business sectors, including 12,9 billion euro from third parties, invested in over 430 companies. The Company is active through five investment divisions: Eurazeo Capital with investments in Iberchem, Albingia or Europcar Mobility Group; Eurazeo PME with investments in Dessange or In’Tech Medical; Eurazeo Growth with investments in Doctolib or PayFit; Eurazeo Brands with investments in consumer and retail, including beauty with Pat McGrath Labs, fashion with Bandier, home with Herschel Supply, leisure, wellness or food companies with Q Mixers; Eurazeo Patrimoine with investments in real estate and infrastructure with C2S Group, Dazeo or Reden Solar. The Company supports also digital sector with Idinvest Venture through investments in Ornikar, an online driving school or M Pharma, a biopharmaceutical company.

  • Revenue in EUR (TTM)353.23m
  • Net income in EUR-77.36m
  • Incorporated1969
  • Employees445.00
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		RF:PAR since
announced		Transaction
value
Rydoo BVAnnounced19 Jun 202419 Jun 2024Announced-8.89%--
Data delayed at least 15 minutes, as of Nov 06 2024 11:02 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.